Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01351467 · ClinicalTrials.gov registry record
Web-based Genetic Research on Parkinson's Disease
A clinical trial of Parkinson's Disease, sponsored by 23andMe.
- Completed
- Registry status
- 13,576
- Enrollment target
- 1
- Study location
NCT01351467 is a study of Parkinson's Disease that has completed, run by 23andMe. The registered enrollment target is 13,576 participants, above the 555-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (2346% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01351467, a study of Parkinson's Disease, has completed, sponsored by 23andMe.
- COMPLETED
- Registry status
- 13,576 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.
Conditions Studied
Study Locations (1)
California
- Www.23Andme.Com/Pd - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,576 participants |
| Start Date | 2009-04 |
| Est. Completion | 2021-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01351467
The ClinicalTrials.gov registry entry for NCT01351467 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13,576 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 555-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (2346% higher). The listed sponsor is 23andMe, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01351467 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01351467 about?
NCT01351467 is a clinical study titled "Web-based Genetic Research on Parkinson's Disease". The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.
What is the current status of trial NCT01351467?
This trial is currently completed. The enrollment target is 13,576 participants. The study started on 2009-04. Estimated completion is 2021-06-23.
What conditions does trial NCT01351467 study?
This clinical trial studies the following conditions: Parkinson's Disease.
Who is sponsoring clinical trial NCT01351467?
This trial is sponsored by 23andMe, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01351467 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.